These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 3519416

  • 1. Effects of a new loop diuretic (muzolimine) in cirrhosis with ascites: comparison with furosemide.
    Bernardi M, De Palma R, Trevisani F, Santini C, Patrono D, Motta R, Servadei D, Gasbarrini G.
    Hepatology; 1986; 6(3):400-5. PubMed ID: 3519416
    [Abstract] [Full Text] [Related]

  • 2. Comparative pharmacodynamics of furosemide and muzolimine in cirrhosis. Study on renal sodium and potassium handling and renin-aldosterone axis.
    Bernardi M, De Palma R, Trevisani F, Santini C, Servadei D, Gasbarrini G.
    Z Kardiol; 1985; 74 Suppl 2():129-34. PubMed ID: 3890391
    [Abstract] [Full Text] [Related]

  • 3. Advantages of the new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites. A randomized, double blind cross-over trial.
    Gerbes AL, Bertheau-Reitha U, Falkner C, Jüngst D, Paumgartner G.
    J Hepatol; 1993 Mar; 17(3):353-8. PubMed ID: 8315263
    [Abstract] [Full Text] [Related]

  • 4. The diuretic effect of muzolimine (Bay g 2821) on hepatogenic ascites.
    Heinrich F, Loew D, Dýcka J.
    Curr Med Res Opin; 1993 Mar; 4(10):706-15. PubMed ID: 800972
    [Abstract] [Full Text] [Related]

  • 5. Muzolimine in chronic renal failure: a study in 16 patients.
    Stratta P, Dogliani M, Squiccimarro G, Colla L, Vercellone A.
    Z Kardiol; 1985 Mar; 74 Suppl 2():125-8. PubMed ID: 4002786
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.
    Arroyo V, Bosch J, Casamitjana R, Cabrera J, Rivera F, Rodés J.
    Gut; 1980 Oct; 21(10):855-9. PubMed ID: 7439805
    [Abstract] [Full Text] [Related]

  • 10. Muzolimine therapy in patients with congestive heart failure in comparison with furosemide pretreatment. Effect on digoxin plasma concentration.
    Kahles H, Ertl G, Riegger G, Liebau G, Kochsiek K.
    Z Kardiol; 1985 Oct; 74 Suppl 2():24-6. PubMed ID: 4002799
    [Abstract] [Full Text] [Related]

  • 11. A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients.
    Gatta A, Angeli P, Caregaro L, Menon F, Sacerdoti D, Merkel C.
    Hepatology; 1991 Aug; 14(2):231-6. PubMed ID: 1860680
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites.
    Kalambokis G, Economou M, Kosta P, Papadimitriou K, Tsianos EV.
    J Clin Gastroenterol; 2006 Apr; 40(4):342-6. PubMed ID: 16633107
    [Abstract] [Full Text] [Related]

  • 16. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
    Kalambokis G, Economou M, Fotopoulos A, Bokharhii JA, Katsaraki A, Tsianos EV.
    Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.